NL7206302A - - Google Patents

Info

Publication number
NL7206302A
NL7206302A NL7206302A NL7206302A NL7206302A NL 7206302 A NL7206302 A NL 7206302A NL 7206302 A NL7206302 A NL 7206302A NL 7206302 A NL7206302 A NL 7206302A NL 7206302 A NL7206302 A NL 7206302A
Authority
NL
Netherlands
Application number
NL7206302A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of NL7206302A publication Critical patent/NL7206302A/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D249/00Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/081,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
NL7206302A 1971-05-11 1972-05-10 NL7206302A (en:Method)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US14241871A 1971-05-11 1971-05-11

Publications (1)

Publication Number Publication Date
NL7206302A true NL7206302A (en:Method) 1972-11-14

Family

ID=22499766

Family Applications (1)

Application Number Title Priority Date Filing Date
NL7206302A NL7206302A (en:Method) 1971-05-11 1972-05-10

Country Status (9)

Country Link
US (2) US3681343A (en:Method)
AU (1) AU472686B2 (en:Method)
BE (1) BE783273A (en:Method)
CH (3) CH572485A5 (en:Method)
DE (1) DE2221790A1 (en:Method)
FR (1) FR2137713B1 (en:Method)
GB (2) GB1380880A (en:Method)
NL (1) NL7206302A (en:Method)
ZA (1) ZA722560B (en:Method)

Families Citing this family (51)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2156472A1 (de) 1970-11-23 1972-05-31 Ciba-Geigy Ag, Basel (Schweiz) Verfahren zur Herstellung von neuen Diazepinderivaten
JPS4932874B1 (en:Method) * 1970-12-11 1974-09-03
US3946032A (en) * 1971-04-08 1976-03-23 Ciba-Geigy Corporation Acetal derivatives of 6-phenyl-4H-s-triazolo[4,3-a][1,4]benzodiazepine-1-carboxaldehyde
CH545302A (de) * 1971-04-08 1974-01-13 Ciba Geigy Ag Verfahren zur Herstellung von neuen Triazolo-benzodiazepinderivaten
US4902794A (en) * 1971-04-28 1990-02-20 The Upjohn Company Triazolo-benzodiazepines
US4250094A (en) * 1971-04-28 1981-02-10 The Upjohn Company 1-(Aminoalkyl) substituted-6-phenyl-4H-s-triazolo[4,3-a][1,4]benzodiazepines
DE2308280A1 (de) * 1971-11-15 1973-09-06 Ciba Geigy Ag Verfahren zur herstellung von neuen diazepinderivaten
US3886174A (en) * 1971-11-22 1975-05-27 Upjohn Co 1-Substituted-6-phenyl-4H-s-triazolo{8 4,3-a{9 {8 1,4{9 benzodiazepines
CH567031A5 (en:Method) * 1972-05-18 1975-09-30 Ciba Geigy Ag
US3879406A (en) * 1972-07-13 1975-04-22 Hoffmann La Roche Preparation of triazolobenzodiazepines
IE38931B1 (en) * 1973-03-09 1978-07-05 Lipha Triazolobenzodiazepines
IE41197B1 (en) 1973-05-29 1979-11-07 Squibb & Sons Inc 4h-s-triazolo (4,3-a)(1,5)benzodiazepin-5-ones
US4213982A (en) 1973-05-29 1980-07-22 E. R. Squibb & Sons, Inc. Novel 4H-S-triazolo[4,3-A] [1,5]benzodiazepin-5-ones
AT338799B (de) * 1974-03-02 1977-09-12 Boehringer Sohn Ingelheim Verfahren zur herstellung neuer substituierter 6-aryl-4h-s-triazolo-(3,4c)-thieno-(2,3e)-1,4-diazepine und ihrer salze
JPS5747914B2 (en:Method) * 1974-04-12 1982-10-13
US3910944A (en) * 1974-11-20 1975-10-07 Upjohn Co Spiro(cyclopropane-1,4{40 -(4H)-s-triazolo-(4,3-a)(1,4)benzodiazepines)
US4044016A (en) * 1975-01-13 1977-08-23 Hoffmann-La Roche Inc. Preparation of triazolo benzodiazepines and novel compounds
US4018788A (en) * 1975-06-16 1977-04-19 The Upjohn Company 6-(O-Halophenyl)-1-methyl-4H-s-triazolo[4,3-a][1,4]-benzodiazepine
US4226772A (en) * 1976-03-15 1980-10-07 The Upjohn Company 1-[(Dialkylamino)methyl]-6-phenyl-4H-s-[4,3,-a][1,4]triazolobenzodiazepine N1 -oxide
US4009175A (en) * 1976-03-15 1977-02-22 The Upjohn Company 1-[(Aminooxy)-methyl]-6-substituted-4H-s-triazolo[4,3-a][1,4] benzodiazepines
US4415583A (en) * 1980-03-27 1983-11-15 The Upjohn Company Process for inducing hypnosis
US4374842A (en) * 1980-04-18 1983-02-22 Shionogi & Co., Ltd. 4,1-Benzoxazepines and compositions
US4479959A (en) * 1981-01-29 1984-10-30 The Upjohn Company Process for inducing hypnosis
US4444781A (en) * 1981-04-06 1984-04-24 The Upjohn Company Process for inducing hypnosis
MX362384B (es) 2010-05-14 2019-01-15 Dana Farber Cancer Inst Inc Composiciones y metodos para tratar neoplasias, enfermedades inflamatorias y otros trastornos.
CN103180318B (zh) 2010-05-14 2017-05-10 达那-法伯癌症研究所 雄性避孕组合物以及使用方法
EP2569434B1 (en) 2010-05-14 2019-09-04 Dana-Farber Cancer Institute, Inc. Compositions and methods for treating leukemia and related disorders
AU2015201727B2 (en) * 2010-05-14 2018-03-08 Dana-Farber Cancer Institute, Inc. Compositions and methods for treating neoplasia, inflammatory disease and other disorders
AR084070A1 (es) 2010-12-02 2013-04-17 Constellation Pharmaceuticals Inc Inhibidores del bromodominio y usos de los mismos
US9249161B2 (en) 2010-12-02 2016-02-02 Constellation Pharmaceuticals, Inc. Bromodomain inhibitors and uses thereof
EP2705039B1 (en) 2011-05-04 2017-07-26 Constellation Pharmaceuticals, Inc. Bromodomain inhibitors and uses thereof
WO2012174487A2 (en) 2011-06-17 2012-12-20 Constellation Pharmaceuticals, Inc. Bromodomain inhibitors and uses thereof
EP2864336B1 (en) 2012-06-06 2016-11-23 Constellation Pharmaceuticals, Inc. Benzo[b]isoxazoloazepine bromodomain inhibitors and uses thereof
TWI602820B (zh) 2012-06-06 2017-10-21 星宿藥物公司 溴域抑制劑及其用途
US9975896B2 (en) 2013-07-25 2018-05-22 Dana-Farber Cancer Institute, Inc. Inhibitors of transcription factors and uses thereof
US11446309B2 (en) 2013-11-08 2022-09-20 Dana-Farber Cancer Institute, Inc. Combination therapy for cancer using bromodomain and extra-terminal (BET) protein inhibitors
JP2017504653A (ja) 2014-01-31 2017-02-09 ダナ−ファーバー キャンサー インスティテュート, インコーポレイテッド ジアミノピリミジンベンゼンスルホン誘導体およびその使用
WO2015117087A1 (en) 2014-01-31 2015-08-06 Dana-Farber Cancer Institute, Inc. Uses of diazepane derivatives
MX377534B (es) 2014-02-28 2025-03-10 Tensha Therapeutics Inc Compuestos para usarse en el tratamiento de hiperinsulinemia.
CN106687463B (zh) 2014-06-20 2019-04-09 星座制药公司 一种乙酰胺类化合物的晶型
EP3177626A4 (en) 2014-08-08 2017-12-27 Dana Farber Cancer Institute, Inc. Diazepane derivatives and uses thereof
BR112017002190A2 (pt) 2014-08-08 2017-11-21 Dana Farber Cancer Inst Inc derivados de di-hidropteridinona e usos dos mesmos
BR112017008714A2 (pt) 2014-10-27 2017-12-19 Tensha Therapeutics Inc inibidores de bromodomínio
EP3307728A4 (en) 2015-06-12 2019-07-17 Dana Farber Cancer Institute, Inc. COMBINATION THERAPY OF TRANSCRIPTION INHIBITORS AND CHINESE INHIBITORS
BR112018004617A2 (pt) 2015-09-11 2018-09-25 Dana Farber Cancer Inst Inc acetamida tienotriazoldiazepinas e usos das mesmas
CR20180200A (es) 2015-09-11 2018-05-31 Dana Farber Cancer Inst Inc Ciano tienotriazolpirazinas y usos de las mismas
WO2017091673A2 (en) 2015-11-25 2017-06-01 Dana-Farber Cancer Institute, Inc. Bivalent bromodomain inhibtors and uses thereof
WO2018206820A1 (en) 2017-05-12 2018-11-15 Mavalon Therapeutics Limited Substituted heterocyclic compounds as allosteric modulators of group ii metabotropic glutamate receptors
MX2022011708A (es) * 2020-03-31 2022-10-07 Hoffmann La Roche Derivados de benzodiazepinas como moduladores alostericos positivos (pam) de acido gamma-aminobutirico (gaba) a gamma1.
CN118019742A (zh) 2021-09-29 2024-05-10 豪夫迈·罗氏有限公司 作为GABA A γ1 PAM的新颖苯并二氮杂䓬衍生物
AU2022360084A1 (en) 2021-10-06 2024-03-28 F. Hoffmann-La Roche Ag Benzodiazepine derivatives as positive allosteric modulators of the gaba a gamma1 receptor

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH540247A (de) * 1967-04-21 1973-09-28 Ciba Geigy Ag Verfahren zur Herstellung von heterocyclischen, Asthylendoppelbindungen enthaltenden Verbindungen
JPS4837280B1 (en:Method) * 1969-03-08 1973-11-09
YU34997B (en) * 1970-03-27 1980-06-30 Hiroyuki Tawada Process for preparing benzodiazepine derivatives

Also Published As

Publication number Publication date
US3681343A (en) 1972-08-01
CH572485A5 (en:Method) 1976-02-13
FR2137713A1 (en:Method) 1972-12-29
ZA722560B (en) 1973-02-28
BE783273A (fr) 1972-11-10
CH573942A5 (en:Method) 1976-03-31
USRE28505E (en) 1975-08-05
DE2221790A1 (de) 1972-11-23
GB1377435A (en) 1974-12-18
AU4164072A (en) 1973-11-01
CH582180A5 (en:Method) 1976-11-30
AU472686B2 (en) 1976-06-03
GB1380880A (en) 1975-01-15
FR2137713B1 (en:Method) 1975-12-26

Similar Documents

Publication Publication Date Title
FR2137713B1 (en:Method)
AU474595B2 (en:Method)
DE2105480C3 (en:Method)
FR2126136A1 (en:Method)
FR2147873A2 (en:Method)
CH560511A5 (en:Method)
CH580596A5 (en:Method)
BG16642A1 (en:Method)
CH561242A5 (en:Method)
BE789383A (en:Method)
BG17201A1 (en:Method)
CH552843A (en:Method)
CH546017A (en:Method)
CH1259175A4 (en:Method)
BE786545A (en:Method)
CH1088671A4 (en:Method)
BE779092A (en:Method)
BG17860A1 (en:Method)
BG18486A1 (en:Method)
BG16766A1 (en:Method)
BG18483A1 (en:Method)
CH569928A5 (en:Method)
BG16877A1 (en:Method)
CH576450A5 (en:Method)
CH575975A5 (en:Method)

Legal Events

Date Code Title Description
BV The patent application has lapsed